TRDA Competitors & Alternatives
Compare Entrada Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRDA
Main Stock$7.24
Tradestie Score
43
Market Cap
$223.66M
Revenue Growth
-1.0%
Analyst Upside
+159.0%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.51
|
$304.12M | - | 55 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.35
|
$297.23M | - | 57 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.17
|
$293.03M | - | 48 | Compare |
|
OMER
Omeros Corporation
|
$12.94
|
$281.75M | 11.0 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.71
|
$275.54M | - | 44 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.90
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$22.25
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.69
|
$262.67M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$34.41
|
$256.54M | - | 58 | Compare |
More TRDA Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry